SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-002434
Filing Date
2024-01-04
Accepted
2024-01-04 16:06:34
Documents
9
Effectiveness Date
2024-01-04

Document Format Files

Seq Description Document Type Size
1 S-8 d698978ds8.htm S-8 44916
2 EX-5.1 d698978dex51.htm EX-5.1 9772
3 EX-23.2 d698978dex232.htm EX-23.2 2366
4 EX-99.1 d698978dex991.htm EX-99.1 358085
5 EX-99.2 d698978dex992.htm EX-99.2 101449
6 EX-FILING FEES d698978dexfilingfees.htm EX-FILING FEES 19655
7 GRAPHIC g698978dsp8aa.jpg GRAPHIC 748
8 GRAPHIC g698978dsp_8.jpg GRAPHIC 8809
9 GRAPHIC g698978dsp_8a.jpg GRAPHIC 6983
  Complete submission text file 0001193125-24-002434.txt   560644
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276372 | Film No.: 24511853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)